These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cytoimmunologic monitoring after heart and heart-lung transplantation. May RM; Cooper DK; Du Toit ED; Reichart B J Heart Transplant; 1990; 9(2):133-5. PubMed ID: 2319372 [TBL] [Abstract][Full Text] [Related]
3. Cytoimmunologic monitoring in early and late acute cardiac rejection. Fieguth HG; Haverich A; Schäfers HJ; Wahlers T; Herrmann G; Frimpong-Boateng K; Cremer J; Kemnitz J; Borst HG J Heart Transplant; 1988; 7(2):95-101. PubMed ID: 3284990 [TBL] [Abstract][Full Text] [Related]
4. Cytoimmunologic monitoring as an adjunct in monitoring rejection after heart transplantation: results of a 6-year follow-up in heart transplant recipients. Wijngaard PL; Doornewaard H; van der Meulen A; Plomp S; Gmelig Meyling FH; de Jonge N; Schuurman HJ J Heart Lung Transplant; 1994; 13(5):869-75. PubMed ID: 7803429 [TBL] [Abstract][Full Text] [Related]
5. Reliability of cytoimmunological monitoring after heart transplantation by consensus measurement: a multicenter study. Schübel C; Caca K; Dirschedl P; Hammer C; Kempkes BM Transplant Proc; 1990 Oct; 22(5):2317-8. PubMed ID: 2219386 [No Abstract] [Full Text] [Related]
6. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy. Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463 [TBL] [Abstract][Full Text] [Related]
7. Expression of HLA molecules on peripheral blood lymphocytes: a useful monitoring parameter in cardiac transplantation. Blanco-Garcia RM; López-Alvarez MR; Pascual-Figal DA; Polo-Garcia L; Guerra N; Campillo JA; Muro M; Garcia-Alonso AM; Marin-Moreno I; Valdes M; Alvarez-López MR; Minguela A Transplant Proc; 2007 Sep; 39(7):2362-4. PubMed ID: 17889190 [TBL] [Abstract][Full Text] [Related]
8. CsA therapy affects the direct and indirect antigen-presentation pathway in cardiac allograft recipients. van Besouw NM; Vaessen LM; Balk AH; Mochtar B; Claas FH; Weimar W Transplant Proc; 1996 Dec; 28(6):3135-6. PubMed ID: 8962214 [No Abstract] [Full Text] [Related]
11. Value of immunologic monitoring studies of human E, EA, and EAC rosetting lymphocyte subpopulations in renal and cardiac transplantation. Berry CR; Thomas FT; Thomas JM; Mendez-Picon G; Lower RR; Lee HM Surg Forum; 1978; 29():373-5. PubMed ID: 401193 [No Abstract] [Full Text] [Related]
12. Cytoimmunological monitoring to detect rejection after heart transplantation. Jutte NH; Daane R; van den Bemd JM; Hop WC; Essed CE; Simoons ML; Bos E; Weimar W Transplant Proc; 1989 Feb; 21(1 Pt 3):2519-20. PubMed ID: 2650319 [No Abstract] [Full Text] [Related]
13. Immunological reactivity before and after cardiac transplantation. Kaslík J; Kocandrle V; Fabián J; Macurová H; Korcáková L Transplant Proc; 1989 Feb; 21(1 Pt 3):2547. PubMed ID: 2650329 [No Abstract] [Full Text] [Related]
14. Effective suppression of brequinar sodium on accelerated allograft rejection in presensitized recipients. Nozaki S; Ito T; Kamiike W; Uchikoshi F; Ito A; Kuhara A; Nakata S; Shirakura R; Miyata M; Matsuda H Transplant Proc; 1995 Feb; 27(1):451-2. PubMed ID: 7879059 [No Abstract] [Full Text] [Related]
15. Noninvasive monitoring of rejection therapy based on intramyocardial electrograms after orthotopic heart transplantation. Grasser B; Schreier G; Iberer F; Wasler A; Petutschnigg B; Müller H; Prenner G; Hipmair G; Hutten H; Schaldach M; Tscheliessnigg KH Transplant Proc; 1996 Dec; 28(6):3276-7. PubMed ID: 8962272 [No Abstract] [Full Text] [Related]